Open AccessDebate
Author(s) -
Mark L. Fuerst
Publication year - 2019
Publication title -
oncology times
Language(s) - Uncategorized
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000615292.60365.44
Subject(s) - venetoclax , decitabine , azacitidine , medicine , cytarabine , myeloid leukemia , regimen , oncology , gemtuzumab ozogamicin , leukemia , cd33 , dna methylation , biochemistry , gene expression , chemistry , genetics , chronic lymphocytic leukemia , stem cell , biology , cd34 , gene